Cargando…

Metastatic pheochromocytoma to liver without elevation of metanephrines and catecholamines()

INTRODUCTION: Malignant pheochromocytoma represents 10% of all patients with pheochromocytoma. Of these cases, only 5–9% presents without elevation of metanephrines and catecholamines. PRESENTATION OF CASE: A 43-year-old female patient presented with an abdominal tumor. An exploratory laparotomy was...

Descripción completa

Detalles Bibliográficos
Autores principales: López-Gómez, Javier, Salazar-Álvarez, Ma. Alejandra, Adame, Rodrigo Y., Alfaro-Goldaracena, Alejandro, Flores-Vazquez, Erwin R., Gonzalez-Infante, Sergio H., Padilla-Rosciano, Alejandro E., López-Basave, Horacio N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5099279/
https://www.ncbi.nlm.nih.gov/pubmed/27821293
http://dx.doi.org/10.1016/j.ijscr.2016.10.050
_version_ 1782465936425484288
author López-Gómez, Javier
Salazar-Álvarez, Ma. Alejandra
Adame, Rodrigo Y.
Alfaro-Goldaracena, Alejandro
Flores-Vazquez, Erwin R.
Gonzalez-Infante, Sergio H.
Padilla-Rosciano, Alejandro E.
López-Basave, Horacio N.
author_facet López-Gómez, Javier
Salazar-Álvarez, Ma. Alejandra
Adame, Rodrigo Y.
Alfaro-Goldaracena, Alejandro
Flores-Vazquez, Erwin R.
Gonzalez-Infante, Sergio H.
Padilla-Rosciano, Alejandro E.
López-Basave, Horacio N.
author_sort López-Gómez, Javier
collection PubMed
description INTRODUCTION: Malignant pheochromocytoma represents 10% of all patients with pheochromocytoma. Of these cases, only 5–9% presents without elevation of metanephrines and catecholamines. PRESENTATION OF CASE: A 43-year-old female patient presented with an abdominal tumor. An exploratory laparotomy was performed and the final report was a pheochromocytoma. After ten years, multiple liver lesions were detected and surgical treatment was performed. Pathological evaluation revealed a malignant pheochromocytoma with negative margins after 5 years of follow-up without evidence of disease. DISCUSSION: The recurrence rate of malignant pheochromocytoma is 15–20% at ten years and a 5-year survival rate that ranges from 50% to 80%. The presence of synchronous metastases is rare (10–27%), but have been reported until 20 years later with the most common metastatic sites being the local lymph nodes, bone (50%), liver (50%) and lung (30%). The prognostic factor such as size >6 cm, age over 45 years, synchronous metastasis and no tumor excision are related with poor prognosis. CONCLUSION: Surgical treatment offers the best survival rate and the only chance of cure so far and the goal is an R0 resection as in our case. So it should be the treatment of choice.
format Online
Article
Text
id pubmed-5099279
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-50992792016-11-14 Metastatic pheochromocytoma to liver without elevation of metanephrines and catecholamines() López-Gómez, Javier Salazar-Álvarez, Ma. Alejandra Adame, Rodrigo Y. Alfaro-Goldaracena, Alejandro Flores-Vazquez, Erwin R. Gonzalez-Infante, Sergio H. Padilla-Rosciano, Alejandro E. López-Basave, Horacio N. Int J Surg Case Rep Case Report INTRODUCTION: Malignant pheochromocytoma represents 10% of all patients with pheochromocytoma. Of these cases, only 5–9% presents without elevation of metanephrines and catecholamines. PRESENTATION OF CASE: A 43-year-old female patient presented with an abdominal tumor. An exploratory laparotomy was performed and the final report was a pheochromocytoma. After ten years, multiple liver lesions were detected and surgical treatment was performed. Pathological evaluation revealed a malignant pheochromocytoma with negative margins after 5 years of follow-up without evidence of disease. DISCUSSION: The recurrence rate of malignant pheochromocytoma is 15–20% at ten years and a 5-year survival rate that ranges from 50% to 80%. The presence of synchronous metastases is rare (10–27%), but have been reported until 20 years later with the most common metastatic sites being the local lymph nodes, bone (50%), liver (50%) and lung (30%). The prognostic factor such as size >6 cm, age over 45 years, synchronous metastasis and no tumor excision are related with poor prognosis. CONCLUSION: Surgical treatment offers the best survival rate and the only chance of cure so far and the goal is an R0 resection as in our case. So it should be the treatment of choice. Elsevier 2016-10-22 /pmc/articles/PMC5099279/ /pubmed/27821293 http://dx.doi.org/10.1016/j.ijscr.2016.10.050 Text en © 2016 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
López-Gómez, Javier
Salazar-Álvarez, Ma. Alejandra
Adame, Rodrigo Y.
Alfaro-Goldaracena, Alejandro
Flores-Vazquez, Erwin R.
Gonzalez-Infante, Sergio H.
Padilla-Rosciano, Alejandro E.
López-Basave, Horacio N.
Metastatic pheochromocytoma to liver without elevation of metanephrines and catecholamines()
title Metastatic pheochromocytoma to liver without elevation of metanephrines and catecholamines()
title_full Metastatic pheochromocytoma to liver without elevation of metanephrines and catecholamines()
title_fullStr Metastatic pheochromocytoma to liver without elevation of metanephrines and catecholamines()
title_full_unstemmed Metastatic pheochromocytoma to liver without elevation of metanephrines and catecholamines()
title_short Metastatic pheochromocytoma to liver without elevation of metanephrines and catecholamines()
title_sort metastatic pheochromocytoma to liver without elevation of metanephrines and catecholamines()
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5099279/
https://www.ncbi.nlm.nih.gov/pubmed/27821293
http://dx.doi.org/10.1016/j.ijscr.2016.10.050
work_keys_str_mv AT lopezgomezjavier metastaticpheochromocytomatoliverwithoutelevationofmetanephrinesandcatecholamines
AT salazaralvarezmaalejandra metastaticpheochromocytomatoliverwithoutelevationofmetanephrinesandcatecholamines
AT adamerodrigoy metastaticpheochromocytomatoliverwithoutelevationofmetanephrinesandcatecholamines
AT alfarogoldaracenaalejandro metastaticpheochromocytomatoliverwithoutelevationofmetanephrinesandcatecholamines
AT floresvazquezerwinr metastaticpheochromocytomatoliverwithoutelevationofmetanephrinesandcatecholamines
AT gonzalezinfantesergioh metastaticpheochromocytomatoliverwithoutelevationofmetanephrinesandcatecholamines
AT padillaroscianoalejandroe metastaticpheochromocytomatoliverwithoutelevationofmetanephrinesandcatecholamines
AT lopezbasavehoracion metastaticpheochromocytomatoliverwithoutelevationofmetanephrinesandcatecholamines